Sliptin Tablet 50 mg contains Sitagliptin, a potent oral antihyperglycemic agent belonging to the class of Dipeptidyl Peptidase-4 (DPP-4) inhibitors, indicated for the management of type 2 diabetes mellitus in adults. Sitagliptin enhances the body’s natural incretin system, which regulates blood glucose by increasing insulin secretion and decreasing glucagon release in a glucose-dependent manner. This mechanism helps control elevated blood sugar levels while minimizing the risk of hypoglycemia.

Sliptin 50 mg is commonly prescribed for patients with type 2 diabetes who cannot achieve sufficient glycemic control with diet and exercise alone. It can be used as monotherapy or in combination with other antidiabetic medications such as metformin, sulfonylureas, or insulin. This dosage is the standard therapeutic dose for adults and is suitable for most patients requiring effective blood glucose management.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Sitagliptin 50 mg per tablet

Mechanism of Action

Sliptin Tablet 50 mg works by selectively inhibiting Dipeptidyl Peptidase-4 (DPP-4), an enzyme responsible for breaking down incretin hormones:

• GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) stimulate insulin release after meals

• Inhibition of DPP-4 prolongs incretin action, leading to:

  • Increased insulin secretion from pancreatic beta cells in response to elevated glucose

  • Reduced glucagon release from pancreatic alpha cells, lowering hepatic glucose production

• Glucose-dependent action ensures that insulin release is enhanced only when blood sugar is high, reducing the risk of hypoglycemia

• Improves both fasting and postprandial blood glucose levels

Indications

Sliptin Tablet 50 mg is indicated for:

• Management of type 2 diabetes mellitus in adults with inadequate glycemic control from diet and exercise

• Combination therapy with metformin, sulfonylureas, or insulin for improved glycemic control

• Patients seeking an oral once-daily therapy with a low risk of hypoglycemia

• Long-term management of type 2 diabetes as part of a comprehensive treatment plan

Dosage and Administration

• Recommended dose: 50 mg once daily, taken orally with or without food

• Swallow the tablet whole; do not crush or chew

• Take at the same time each day for consistent blood sugar control

• Dose adjustments may be required in patients with moderate to severe renal impairment

• Can be used alone or in combination with other antidiabetic medications as prescribed by a physician

Benefits

• Effectively lowers both fasting and postprandial blood glucose

• Glucose-dependent mechanism reduces risk of hypoglycemia

• Convenient once-daily dosing improves adherence

• Can be safely combined with other antidiabetic agents for better glucose control

• Supports long-term metabolic health and helps prevent diabetes-related complications

Precautions

• Not recommended for type 1 diabetes or diabetic ketoacidosis

• Monitor renal function in patients with kidney impairment

• Maintain diet and exercise regimen alongside medication

• Use during pregnancy and lactation only if clearly justified; consult a healthcare provider

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Common side effects:

• Headache

• Nasopharyngitis

• Mild gastrointestinal discomfort (nausea, diarrhea)

Rare but serious side effects:

• Pancreatitis (persistent abdominal pain, possibly radiating to the back)

• Hypersensitivity reactions, including rash, swelling, or hives

• Severe joint pain or exacerbation of heart failure in predisposed patients

Storage

Store in a cool, dry place below 30°C, away from direct sunlight and moisture. Keep out of reach of children.

Sliptin Tablet 50 mg provides effective glycemic control, enhances insulin response, reduces glucagon secretion, and supports long-term metabolic health in patients with type 2 diabetes.